SCHEMBL9535305

SCHEMBL9535305

O=c1c2c(c3cccnc3n1-c1ccccc1)CCCC2

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FEN1 P39748 1/20 0.55
PDE4A P27815 7/20 0.53
PDE4B Q07343 6/20 0.53
PDE4C Q08493 6/20 0.53
PDE4D Q08499 6/20 0.53
ALDH1A1 P00352 2/20 0.50
TSHR P16473 1/20 0.50
CYP2C19 P33261 1/20 0.50
PDE1A P54750 1/20 0.46
PDE1B Q01064 1/20 0.46
LDHA P00338 1/20 0.44
LOXL3 P58215 1/20 0.44
LOXL2 Q9Y4K0 1/20 0.44
KDM4E B2RXH2 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
DDB1 Q16531 1/20 0.42
CRBN Q96SW2 1/20 0.42
KAT2B Q92831 1/20 0.41
MAPK1 P28482 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9532938 0.97 FEN1 (0.55) FEN1PDE4APDE4BPDE4CPDE4D
SCHEMBL9535601 0.85 MAPT (0.50) FEN1PDE4APDE4BPDE4CPDE4D
SCHEMBL9630056 0.83 FEN1 (0.47) FEN1PDE4APDE4BPDE4CPDE4D
SCHEMBL9629723 0.82 FEN1 (0.48) FEN1PDE4APDE4BPDE4CPDE4D
SCHEMBL9799616 0.80 PDE4A (0.53) FEN1PDE4APDE4BPDE4CPDE4D
SCHEMBL9132364 0.79 FEN1 (0.50) FEN1PDE4APDE4BPDE4CPDE4D
SCHEMBL9799632 0.79 FEN1 (0.50) FEN1PDE4APDE4BPDE4CPDE4D
SCHEMBL9630002 0.79 FEN1 (0.50) FEN1PDE4APDE4BPDE4CPDE4D
SCHEMBL9629153 0.79 FEN1 (0.50) FEN1PDE4APDE4BPDE4CPDE4D
SCHEMBL9532969 0.79 PDE4A (0.52) FEN1PDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0241291-B1 ARYL-SUBSTITUTED NAPHTHYRIDINE AND PYRIDOPYRAZINE DERIVATIVES SCHERING CORPORATION (US) 1993-06-02 EP claimed
US-5045542-A Immune suppression method employing aryl-substituted naphthyridine and pyridopyrazine derivatives SCHERING CORPORATION (US) 1991-09-03 US claimed
EP-0241291-A2 Aryl-substituted naphthyridine and pyridopyrazine derivatives SCHERING CORPORATION (US) 1987-10-14 EP claimed
EP-0241291-B1 ARYL-SUBSTITUTED NAPHTHYRIDINE AND PYRIDOPYRAZINE DERIVATIVES SCHERING CORPORATION (US) 1993-06-02 EP disclosed
US-5045542-A Immune suppression method employing aryl-substituted naphthyridine and pyridopyrazine derivatives SCHERING CORPORATION (US) 1991-09-03 US disclosed
US-5011860-A Aryl-substituted naphthyridine and pyridopyrazine derivatives and their use in treating hyperproliferative skin diseases SCHERING CORPORATION (US) 1991-04-30 US disclosed
US-4882332-A Immune suppression method employing arly-substituted naphthyridine and pyridopyrazine derivatives SCHERING CORPORATION (US) 1989-11-21 US disclosed
US-4866061-A TREATMENT OF ALLERGIC REACTIONS, ULCERS, INFLAMMATION SCHERING CORPORATION (US) 1989-09-12 US disclosed
US-4760073-A Aryl-substituted naphthyridine and pyridopyrazine derivatives, useful as anti-allergic agents SCHERING CORPORATION (US) 1988-07-26 US disclosed
EP-0241291-A2 Aryl-substituted naphthyridine and pyridopyrazine derivatives SCHERING CORPORATION (US) 1987-10-14 EP disclosed